The effect of ibuprofen and caffeine prophylaxis on retinopathy of prematurity

Varsha Bhatt-Mehta1, Robert E Schumacher2

  • 1Department of Clinical Pharmacy, College of Pharmacy; Department of Pediatrics and Communicable Diseases, Michigan Medicine, University of Michigan.

Insights

Prophylactic caffeine and ibuprofen did not affect severe retinopathy of prematurity (ROP) in extremely low birth weight infants. Oxygen exposure at 28 days postnatal age or 36 weeks corrected gestational age was linked to ROP severity.

Area of Science:

  • Neonatal Medicine
  • Ophthalmology
  • Pharmacology

Background:

  • Retinopathy of prematurity (ROP) is a significant cause of visual impairment in premature infants.
  • Caffeine and ibuprofen have shown potential in modulating vascular endothelial growth factor, a key factor in ROP development.

Purpose of the Study:

  • To investigate the effect of prophylactic caffeine and ibuprofen on the incidence of severe ROP in extremely low birth weight infants.
  • To assess the association between oxygen exposure and ROP severity.

Main Methods:

  • Retrospective cohort study of 109 extremely low birth weight infants.
  • Assessed ROP incidence and severity in relation to caffeine and ibuprofen exposure.
  • Analyzed the impact of oxygen exposure at 28 days postnatal age and 36 weeks corrected gestational age.

Main Results:

  • No significant difference in caffeine or ibuprofen exposure was found between infants with severe ROP and those with mild-to-moderate ROP.
  • Infants with severe ROP had significantly lower gestational age.
  • Oxygen exposure at 28 days postnatal age and 36 weeks corrected gestational age was significantly associated with ROP severity.

Conclusions:

  • Prophylactic caffeine and ibuprofen administration did not demonstrate a detectable effect on severe ROP incidence in this cohort.
  • Oxygen exposure is a significant risk factor for ROP severity in extremely low birth weight infants.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
37
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
35
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.5K